Literature DB >> 1882918

Congenital arteriovenous communications and the development of two types of leaking retinal macroaneurysms.

M D Tilanus1, C Hoyng, A F Deutman, J R Cruysberg, A L Aandekerk.   

Abstract

We treated a patient with a rare combination of congenital arteriovenous communications and the development of leaking macroaneurysms of different types. Initially, leaking macroaneurysms developed in the shunt area of the arteriovenous communication; later, a preexistent fusiform macroaneurysm in the afferent arteriole of the congenital communication started leaking. Because exudates and fluid from the leaking macroaneurysms reached the fovea, laser treatment was performed to obliterate the macroaneurysms. We assume that after obliteration of the macroaneurysms with laser in the shunt area, the increase of hydrostatic pressure on the thin wall of the fusiform aneurysm of the afferent artery led to its leaking. We saw no signs of vascular occlusion after laser treatment.

Entities:  

Mesh:

Year:  1991        PMID: 1882918     DOI: 10.1016/s0002-9394(14)76208-7

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  3 in total

Review 1.  Retinal vein occlusion in retinal racemose hemangioma: a case report and literature review of ocular complications in this rare retinal vascular disorder.

Authors:  Xue-jiao Qin; Chao Huang; Kun Lai
Journal:  BMC Ophthalmol       Date:  2014-08-21       Impact factor: 2.209

2.  Optical coherence tomography angiography of fleeting macroaneurysm in retinal racemose angioma.

Authors:  P Mahesh Shanmugam; Sriram Simakurthy; Vinaya Kumar Konana; Rajesh Ramanjulu; K C Divyansh Mishra
Journal:  Indian J Ophthalmol       Date:  2018-09       Impact factor: 1.848

3.  Retinal racemose hemangioma with retinal artery macroaneurysm: Optical coherence tomography angiography (OCTA) findings.

Authors:  Raval Vishal; Oli Avadesh; Rao Srinivas; Das Taraprasad
Journal:  Am J Ophthalmol Case Rep       Date:  2018-06-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.